Development of myeloid leukaemia in children with Down syndrome is a stepwise process. Here, the authors employ scRNA sequencing and phylogenetic analysis on patient samples from various disease stages to define the cellular and molecular features of this stepwise leukaemia development.
- Mi K. Trinh
- Konstantin Schuschel
- Sam Behjati